AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Treatment to protect and / or recover sexual function of the cavernosal nerve (sexual potency) after radical prostatectomy

Technology Application: The compound may be used to treat erectile dysfunction in men who have undergone prostatectomy due to prostate cancer.

Detailed Technology Description: None

Application No.: 8653057

Others: Tech ID/UC Case
22229/2010-964-0

Related Cases
2010-964-0

*Abstract: It is estimated that 1 in 6 men will be diagnosed with prostate cancer in their lifetime. One of the consequences of removing the prostate for prostate cancer is a non-permanent injury of the cavernosal nerve during open radical prostatectomy (RP) or robot-assisted radical prostatectomy (RARP), which may result in post-operative sexual dysfunction. These sexual side effects can severely affect the quality of life for men and their loved ones.

Researchers at the University of California, Irvine have developed a new use for an existing compound that can be used to prevent, mitigate, or treat erectile dysfunction associated with prostate removal surgery.

*IP Issue Date: Feb 18, 2014

*Principal Investigator: Name: Thomas Ahlering
Department:

Name: Douglas Skarecky
Department:

Country/Region: USA

For more information, please click Here